Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: Alternative Support for Rural and Isolated Women in an HMO [Phase 3]
Phase 3 trial conducted at Stanford evaluated alternative support for rural and isolated women in an HMO; the study status is completed.
-
CLINICAL_TRIALS research · 2011-06-30Clinical Trial Update: rTMS in Elderly Depressed:Neuronavegated Study [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating repetitive transcranial magnetic stimulation (rTMS) for depression in elderly…
-
FDA label_change · 2011-06-29FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
FDA records a supplemental application for VIIBRYD (vilazodone hydrochloride) filed by Allergan, Inc., likely seeking changes to the labelin…
-
FDA approval · 2011-06-28FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mirtazapine submitted by Mylan Pharmaceuticals Inc. under an ANDA. This action confirms approval…
-
FDA approval · 2011-06-28FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for mirtazapine (generic) under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-06-28Clinical Trial Update: The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
A completed AstraZeneca-sponsored study aimed to gain an in-depth understanding of patient management and prescription behaviours in schizop…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Personality-targeted Interventions for Adolescent Alcohol Misuse [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating personality-targeted interventions for adolescent alcohol misuse, sponsored by King's College L…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial from King's College London testing a teacher-delivered, personality-targeted intervention for substance m…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression [Phase 4]
A Phase 4 clinical trial comparing Hypericum (St. John's Wort) and Fluoxetine for mild to moderate adolescent depression was terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Investigation of a Combination Treatment of Escitalopram and rTMS [NA]
Clinical trial investigating the combination of escitalopram and repetitive transcranial magnetic stimulation (rTMS) for major depressive di…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Mothers With a History of Depression and Their 10-14 Year Old Daughters
This document provides an update on a completed clinical trial involving mothers with a history of depression and their daughters aged 10-14…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder [Phase 4]
Phase 4 trial comparing early versus delayed switch in medication for major depressive disorder; the study is completed and results were pos…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
This completed clinical trial evaluated changes in metabolic parameters in patients with major depressive disorder, generalized anxiety diso…
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Cysteamine Therapy for Major Depressive Disorder [NA]
This document reports the termination of a clinical trial evaluating cysteamine therapy for major depressive disorder. The update does not p…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain [Phase 4]
The study evaluated the efficacy and safety of Smilon (mirtazapine) in patients with major depressive disorder and chronic pain. It has comp…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of combining citalopram with lithium for depressive mood disorder symptoms in adults has …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Antidepressant Medication Plus Donepezil for Treating Late-life Depression [Phase 4]
Phase 4 clinical trial results from the University of Pittsburgh evaluated combining an antidepressant with donepezil for late-life depressi…
-
CLINICAL_TRIALS research · 2011-06-08Clinical Trial Update: Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial [NA]
A randomized pilot trial comparing Mindfulness-based Behavioral Therapy (MIBT) with Psychodynamic Therapy for adults with Major Depressive D…
-
FDA approval · 2011-06-06FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
The FDA approved a supplemental application for mirtazapine from Aurolife Pharma LLC, updating the regulatory status of the generic product.
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder [Phase 3]
A Phase 3 study evaluating desvenlafaxine succinate sustained release (DVS SR) for major depressive disorder has completed. Results have bee…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Escitalopram and Depression in Elderly Alzheimer's Patients [Phase 3]
Phase 3 trial evaluating escitalopram for depressive symptoms in elderly Alzheimer's patients was terminated.
-
CLINICAL_TRIALS withdrawal · 2011-06-06Clinical Trial Update: Ketamine Frequency Treatment for Major Depressive Disorder [Phase 4]
A Phase 4 clinical trial investigating a ketamine frequency treatment for major depressive disorder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU) [NA]
This entry reports a completed clinical trial evaluating an intervention designed to decrease anxiety in parents of infants in the NICU.
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Olanzapine Treatment of Patients With Bipolar I Disorder [Phase 3]
Phase 3 clinical trial evaluating olanzapine for bipolar I disorder has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Neurophysiologic Monitoring of Antidepressant Treatment [Phase 4]
A Phase 4 clinical trial conducted at UCLA evaluated neurophysiologic monitoring during antidepressant treatment for major depressive disord…